Literature DB >> 18181006

Liver regeneration and tumor stimulation--a review of cytokine and angiogenic factors.

Christopher Christophi1, Nadia Harun, Theodora Fifis.   

Abstract

Liver resection for metastatic (colorectal carcinoma) tumors is often followed by a significant incidence of tumor recurrence. Cellular and molecular changes resulting from hepatectomy and the subsequent liver regeneration process may influence the kinetics of tumor growth and contribute to recurrence. Clinical and experimental evidence suggests that factors involved in liver regeneration may also stimulate the growth of occult tumors and the reactivation of dormant micrometastases. An understanding of the underlying changes may enable alternative strategies to minimize tumor recurrence and improve patient survival after hepatectomy.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18181006     DOI: 10.1007/s11605-007-0459-6

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  187 in total

1.  Inhibition of growth factor production and angiogenesis in human cancer cells by ZD1839 (Iressa), a selective epidermal growth factor receptor tyrosine kinase inhibitor.

Authors:  F Ciardiello; R Caputo; R Bianco; V Damiano; G Fontanini; S Cuccato; S De Placido; A R Bianco; G Tortora
Journal:  Clin Cancer Res       Date:  2001-05       Impact factor: 12.531

Review 2.  Insulin-like growth factor-binding proteins in serum and other biological fluids: regulation and functions.

Authors:  S Rajaram; D J Baylink; S Mohan
Journal:  Endocr Rev       Date:  1997-12       Impact factor: 19.871

Review 3.  Liver regeneration: a picture emerges from the puzzle.

Authors:  D LaBrecque
Journal:  Am J Gastroenterol       Date:  1994-08       Impact factor: 10.864

4.  Analysis of biological effects and signaling properties of Flt-1 (VEGFR-1) and KDR (VEGFR-2). A reassessment using novel receptor-specific vascular endothelial growth factor mutants.

Authors:  H Gille; J Kowalski; B Li; J LeCouter; B Moffat; T F Zioncheck; N Pelletier; N Ferrara
Journal:  J Biol Chem       Date:  2000-10-31       Impact factor: 5.157

Review 5.  Surgical therapy of hepatic colorectal metastasis.

Authors:  Y Fong
Journal:  CA Cancer J Clin       Date:  1999 Jul-Aug       Impact factor: 508.702

6.  Liver resection for colorectal metastases.

Authors:  Y Fong; A M Cohen; J G Fortner; W E Enker; A D Turnbull; D G Coit; A M Marrero; M Prasad; L H Blumgart; M F Brennan
Journal:  J Clin Oncol       Date:  1997-03       Impact factor: 44.544

Review 7.  Chemotherapy-associated hepatotoxicity and surgery for colorectal liver metastases.

Authors:  D Zorzi; A Laurent; T M Pawlik; G Y Lauwers; J-N Vauthey; E K Abdalla
Journal:  Br J Surg       Date:  2007-03       Impact factor: 6.939

8.  Role of growth hormone (GH) in liver regeneration.

Authors:  Patricia A Pennisi; John J Kopchick; Snorri Thorgeirsson; Derek LeRoith; Shoshana Yakar
Journal:  Endocrinology       Date:  2004-07-08       Impact factor: 4.736

Review 9.  Vascular endothelial growth factor as a target for anticancer therapy.

Authors:  Napoleone Ferrara
Journal:  Oncologist       Date:  2004

10.  Blockade of epidermal growth factor receptor signaling on tumor cells and tumor-associated endothelial cells for therapy of human carcinomas.

Authors:  Cheryl H Baker; Daniel Kedar; Marya F McCarty; Rachel Tsan; Kristen L Weber; Corazon D Bucana; Isaiah J Fidler
Journal:  Am J Pathol       Date:  2002-09       Impact factor: 4.307

View more
  12 in total

Review 1.  COX-2 in liver, from regeneration to hepatocarcinogenesis: what we have learned from animal models?

Authors:  Paloma Martín-Sanz; Rafael Mayoral; Marta Casado; Lisardo Boscá
Journal:  World J Gastroenterol       Date:  2010-03-28       Impact factor: 5.742

Review 2.  Effect of liver regeneration on malignant hepatic tumors.

Authors:  Ji-Hua Shi; Pål-Dag Line
Journal:  World J Gastroenterol       Date:  2014-11-21       Impact factor: 5.742

3.  Deficiency of the oxygen sensor PHD1 augments liver regeneration after partial hepatectomy.

Authors:  Martin Mollenhauer; Judit Kiss; Johanna Dudda; Johanna Kirchberg; Nuh Rahbari; Praveen Radhakrishnan; Thomas Niemietz; Vanessa Rausch; Jürgen Weitz; Martin Schneider
Journal:  Langenbecks Arch Surg       Date:  2012-09-11       Impact factor: 3.445

4.  Breast and other cancer dormancy as a therapeutic endpoint: speculative recombinant T cell receptor ligand (RTL) adjuvant therapy worth considering?

Authors:  Tibor Bakács; Jitendra N Mehrishi
Journal:  BMC Cancer       Date:  2010-06-02       Impact factor: 4.430

Review 5.  Portal vein embolization effect on colorectal cancer liver metastasis progression: Lessons learned.

Authors:  Eman Al-Sharif; Eve Simoneau; Mazen Hassanain
Journal:  World J Clin Oncol       Date:  2015-10-10

6.  Changes in growth factor levels after thermal ablation in a murine model of colorectal liver metastases.

Authors:  Theodora Fifis; Caterina Malcontenti-Wilson; Jason Amijoyo; Beatrice Anggono; Vijayaragavan Muralidharan; Mehrdad Nikfarjam; Christopher Christophi
Journal:  HPB (Oxford)       Date:  2011-03-02       Impact factor: 3.647

7.  Tumour growth stimulation following partial hepatectomy in mice is associated with increased upregulation of c-Met.

Authors:  Nadia Harun; Patricia Costa; C Christophi
Journal:  Clin Exp Metastasis       Date:  2013-07-31       Impact factor: 5.150

8.  Angiogenesis: multiple masks in hepatocellular carcinoma and liver regeneration.

Authors:  Ji-An Chen; Ming Shi; Jin-Qing Li; Chao-Nan Qian
Journal:  Hepatol Int       Date:  2010-07-29       Impact factor: 6.047

9.  Profiling bladder cancer organ site-specific metastasis identifies LAMC2 as a novel biomarker of hematogenous dissemination.

Authors:  Steven Christopher Smith; Brian Nicholson; Matthew Nitz; Henry F Frierson; Mark Smolkin; Garret Hampton; Wael El-Rifai; Dan Theodorescu
Journal:  Am J Pathol       Date:  2009-01-15       Impact factor: 4.307

Review 10.  Tumour progression and liver regeneration--insights from animal models.

Authors:  Chetana Lim; Francois Cauchy; Daniel Azoulay; Olivier Farges; Maxime Ronot; Marc Pocard
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2013-04-09       Impact factor: 46.802

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.